Decoy Therapeutics holds annual shareholder meeting
DCOY•Annual shareholder meeting results
- Decoy Therapeutics held its annual shareholder meeting on July 14, 2026.
- Shareholders backed the board’s slate of Class II director nominees.
- Shareholders ratified Ernst & Young as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.




